TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy.

Miriam Valenzuela-CardenasCody GowanParker DryjaMee Y BarteeEric Bartee

Published in: Journal for immunotherapy of cancer (2022)

These data suggest that some aspects of OV-induced inflammation might represent a double-edged sword during therapy and that specific blockade of TNF might enhance the efficacy of these treatments.

Keyphrases

rheumatoid arthritis
oxidative stress
high glucose
diabetic rats
electronic health record
big data
stem cells
machine learning
endothelial cells
smoking cessation